New Delhi, April 4 (IANS) India’s drug regulators are stepping up oversight of fast-growing weight-loss and diabetes therapies, particularly GLP-1 receptor agonists, amid rising demand and the anticipated entry of cheaper generic versions into the domestic market.The move comes as the Indian Pharmacopoeia Commission (IPC), which functions under the Ministry of Health, has been tasked with systematically collecting and analysing adverse event reports linked to these drugs.The initiative aims to…
Latest Drug Controller General of India News & Updates
New Delhi, April 1 (IANS) The Drug Controller General of India has stepped up regulatory surveillance against unauthorised sale and promotion of type 2 diabetes drugs also known as GLP-1 drugs, the government said on Wednesday.In recent weeks, 49 businesses were audited and inspected across the country, including online pharmacy warehouses, drug wholesalers, retailers, and weight loss clinics, an official statement said.These inspections spanned multiple regions across India and focused on ident…